Award year: 2023
Category: Scholarship / Grant
Type: Reinhart Koselleck-Projekte
Awarding organization: Deutsche Forschungsgemeinschaft (DFG)
A multi-faceted approach has to be taken to fighting cancer, which means that the most successful treatment strategy is likely to involve an intelligent combination of drugs, often tailored to the individual patient’s needs, that target various weaknesses. Thomas Brabletz, a renowned cancer researcher, hopes to pinpoint these weaknesses, and is focusing on a relentless opponent that is still almost invariably fatal, even today and in spite of the major advancements made over recent years: metastatic cancer.